Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Role of Ginkgo Biloba Extract in IUGR

Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Веза се чува у привремену меморију
СтатусЗавршено
Спонзори
Assiut University

Кључне речи

Апстрактан

The use of herbal medicinal products is increasing enormously in recent years, mainly among women, who use them for the most varied purposes, such as in menstrual problems, menopausal symptoms, mood disturbances and to strengthen their bones. Most of these benefits are due to the flavonoids present in these products. These flavonoids have anticarcinogenic, antiviral, antioxidant and antiinflammatory activities, as well as being used in the treatment of osteoporosis, menopausal symptoms and cardiovascular diseases . Besides the benefits from the consumption of flavonoids, little is known about their safety and potentially harmful toxic effects, such as mutagenicity and genotoxicity which might occur if taken in large doses . Safety of Ginkgo biloba during pregnancy or lactation was not criticized in literature. Roasted and raw ginkgo seed were not reported in the evidence-based medicine literature as being either safe or contraindicated in pregnancy or lactation. A higher incidence of postpartum hemorrhage was reported in the literature when associated with a 3-month ingestion of Ginkgo Biloba extract. Flavonoids are components of Ginkgo biloba L. (Ginkgoaceae), a medicinal plant widely used by the population . G. biloba has its origin in China, Korea and Japan where its fruits and leaves have been used as food and medicine for a long time.
The extract of G. biloba (EGb) is composed of different terpene trilactones, i.e., ginkgolides A, B, C, J and bilobalide, many flavonol glycosides, biflavones and alkylphenols . The major flavonoids in the extract are kaempferol, quercetin and isorhamnetin] whose metabolites were found in the blood of rats and in human urine after oral administration of EGb. Due to its actions as an anti-inflammatory and antioxidant, EGb has been largely used in the treatment of Alzheimer's disease, pre-menstrual syndrome, cerebrovascular insufficiency and peripheral arterial occlusive disease . In folk medicine, EGb is used as a vermifuge, to induce labor, for the treatment of bronchitis, chronic rhinitis, chilblains, arthritis and edema . The aim of this study was to evaluate the effect of oral supplementation of Ginkgo Biloba extract on the fetal weight as well as feto-maternal blood flow in cases of intrauterine growth restriction.

Датуми

Последња верификација: 02/29/2016
Фирст Субмиттед: 04/20/2015
Предвиђена пријава послата: 04/22/2015
Прво објављено: 04/23/2015
Послато последње ажурирање: 03/19/2016
Последње ажурирање објављено: 03/21/2016
Стварни датум почетка студије: 04/30/2014
Процењени датум примарног завршетка: 09/30/2015
Предвиђени датум завршетка студије: 11/30/2015

Стање или болест

Intrauterine Growth Restriction (IUGR)

Интервенција / лечење

Drug: Ginkgo Biloba Extract group

Other: Placebo group

Фаза

Фаза 2

Групе руку

АрмИнтервенција / лечење
Active Comparator: Ginkgo Biloba Extract group
This group received Ginko Biloba, two tablets per day
Drug: Ginkgo Biloba Extract group
Placebo Comparator: Placebo group
This group received placebo two tablets per day .
Other: Placebo group

Критеријуми

Узраст подобан за студирање 20 Years До 20 Years
Полови подобни за студирањеFemale
Прихвата здраве волонтереда
Критеријуми

Inclusion Criteria:

- Pregnant women in their third trimester (28-30 weeks of gestation).

- Pregnant women whose pregnancy was complicated with intra uterine growth restriction (IUGR).

- Normal Doppler indices in uterine, umbilical and middle cerebral arteries at time of recruitment.

Exclusion Criteria:

- Multiple pregnancies,

- Hypertension,

- Fetal congenital anomalies,

- Previous history of congenital anomalies or chromosomal abnormalities.

- Diabetes Mellitus

- Premature pre-labor rupture of membranes

- Antepartum hemorrhage

Исход

Примарне мере исхода

1. Fetal weight (gm) [one and half year]

Секундарне мере исхода

1. Doppler blood flow changes in uterine arteries indices [one and half year]

2. Doppler blood flow changes in umbilical arteries indices [one and half year]

3. Doppler blood flow changes in middle cerebral artery indices [one and half year]

Придружите се нашој
facebook страници

Најкомплетнија база лековитог биља подржана науком

  • Ради на 55 језика
  • Биљни лекови потпомогнути науком
  • Препознавање биљака по слици
  • Интерактивна ГПС мапа - означите биље на локацији (ускоро)
  • Читајте научне публикације повезане са вашом претрагом
  • Претражите лековито биље по њиховим ефектима
  • Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима

Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима

Google Play badgeApp Store badge